Get started
Author

Kathy M. Ceballos

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months
2018 · Gina Suzanne Ogilvie, Dirk van Niekerk, et al. · JAMA · 283
PDF
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
2008 · Blaise Clarke, Anna V Tinker, et al. · Modern Pathology · 279
PDF
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV‐based primary screening to liquid‐based cytology for cervical cancer
2016 · Gina S. Ogilvie, Mel Krajden, et al. · International Journal of Cancer · 102
PDF
Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study
2012 · G S Ogilvie, M Krajden, et al. · British Journal of Cancer · 84
PDF
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)
2010 · Gina S Ogilvie, Dirk J van Niekerk, et al. · BMC Cancer · 84
PDF
BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer
2016 · John P. Stamp, C. Blake Gilks, et al. · International Journal of Gynecological Cancer · 59
Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
2015 · Darrel A. Cook, Wendy Mei, et al. · BMC Cancer · 51
PDF
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial
2018 · Gina Suzanne Ogilvie, Dirk van Niekerk, et al. · Obstetrical & Gynecological Survey · 49
Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial
2016 · Darrel A. Cook, Laurie W. Smith, et al. · Journal of Clinical Virology · 45
PDF
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial
2018 · Darrel A. Cook, Laurie W. Smith, et al. · Journal of Clinical Virology · 29
Interobserver Agreement for Assessing Invasion in Stage 1A Vulvar Squamous Cell Carcinoma
2013 · Amal Abdel-Mesih, Dean Daya, et al. · The American Journal of Surgical Pathology · 23
Reproducibility of the Histological Diagnosis of Cervical Dysplasia Among Pathologists From 4 Continents
2008 · Kathy M. Ceballos, William Chapman, et al. · International Journal of Gynecological Pathology · 22
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial
2016 · Andrew J Coldman, Lovedeep Gondara, et al. · British Journal of Cancer · 14
PDF
Facilitated “Fast Track” Referral Reduces Time from Abnormal Screening Mammogram to Diagnosis
2008 · Marilyn J. Borugian, Lisa Kan, et al. · Canadian Journal of Public Health · 13
Tissue Microarray for Routine Clinical Breast Biomarker Analysis
2010 · Thomas A. Thomson, Chen Zhou, et al. · American Journal of Clinical Pathology · 11
Post–Loop Electrosurgical Excision Procedure High-Risk Human Papillomavirus Testing as a Test of Cure: The British Columbia Experience
2017 · Kathy M. Ceballos, Marette Lee, et al. · Journal of Lower Genital Tract Disease · 9
Lipomembranous panniculitis: report of a case
2007 · Nabeel Al-Brahim, Kathy Ceballos, et al. · Annals of Diagnostic Pathology · 8
Disease detection at the 48‐month exit round of the HPV FOCAL cervical cancer screening trial in women per‐protocol eligible for routine screening
2019 · Andrew J. Coldman, Dirk van Niekerk, et al. · International Journal of Cancer · 3
PDF
Endometrioid Cystadenofibroma of the Ovary with Pelvic Lymph Node Involvement
2006 · Kathy Ceballos, Dean Daya · International Journal of Gynecological Pathology · 2
O17.1 HPV focal 48 month exit results by age for women HPV or LBC negative at baseline screening
2019 · Gina Ogilvie, Dirk Van Niekerk, et al. · Sexually Transmitted Infections · 1
PDF
O-GYN-ONCOL-MD-022 Post-LEEP HPV Testing in the British Columbia Cervical Cancer Screening Program (BC CCSP)
2016 · M. Lee, Kathy Ceballos, et al. · Journal of Obstetrics and Gynaecology Canada
Additional file 1: of Comparison of the Roche cobasŽ 4800 and Digene Hybrid CaptureŽ 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
2015 · Cook, Darrel, Mei, Wendy, et al. · Figshare
Centralized Breast Cancer Biomarker Testing: A Value-Added Role in Guiding Patient Management
2013 · Ananta Gurung, Chen Zhou, et al. · American Journal of Clinical Pathology
Works count: 26
Citation count: 1,171
H-index: 13
I10-index: 15
Year
Topic
Type